1. Home
  2. MTEX vs ADXN Comparison

MTEX vs ADXN Comparison

Compare MTEX & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mannatech Incorporated

MTEX

Mannatech Incorporated

N/A

Current Price

$5.50

Market Cap

10.5M

Sector

Health Care

ML Signal

N/A

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

N/A

Current Price

$5.86

Market Cap

8.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MTEX
ADXN
Founded
1993
2002
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
8.6M
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
MTEX
ADXN
Price
$5.50
$5.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.5K
2.1K
Earning Date
04-15-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$108,038,000.00
N/A
Revenue This Year
N/A
$86.57
Revenue Next Year
N/A
N/A
P/E Ratio
$11.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.80
$5.41
52 Week High
$12.45
$12.05

Technical Indicators

Market Signals
Indicator
MTEX
ADXN
Relative Strength Index (RSI) 56.80 35.30
Support Level $4.47 $5.49
Resistance Level $5.83 $7.40
Average True Range (ATR) 0.43 0.18
MACD 0.14 -0.08
Stochastic Oscillator 92.12 0.00

Price Performance

Historical Comparison
MTEX
ADXN

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: